US equities
|
NVDA
$150.62
▼-3.12%
MU
$703.12
▼-1.31%
AMD
$526.04
▲+4.50%
SPCX
$143.43
▲+1.22%
SNDK
$775.46
▼-2.73%
AMZN
$267.32
▲+3.66%
TSLA
$385.05
▲+1.30%
MSFT
$507.19
▲+0.19%
NVDA
$150.62
▼-3.12%
MU
$703.12
▼-1.31%
AMD
$526.04
▲+4.50%
SPCX
$143.43
▲+1.22%
SNDK
$775.46
▼-2.73%
AMZN
$267.32
▲+3.66%
TSLA
$385.05
▲+1.30%
MSFT
$507.19
▲+0.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Autonomix Medical, Inc. - Common Stock
(NQ:
AMIX
)
1.090
+0.010 (+0.93%)
Delayed Quote
Updated: 3:47 PM EST, Nov 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Autonomix Medical, Inc. - Common Stock
Kartoon Studios (NYSE: TOON) Among ADGM, QNME, AMIX Strengthens Consumer Strategy with Former Activision Blizzard Licensing Executive
August 04, 2026
Via
AB Newswire
Stocks Under $1: AMIX, TOON, SOAR, SJ, BNRG, PNPNF, PRSO – Double-Digit 2026 Watchlist
December 30, 2025
Via
AB Newswire
JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
July 22, 2025
Via
ACCESS Newswire
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology
April 15, 2024
Via
Get News
Autonomix Medical, Inc. (NASDAQ:AMIX) to Present at Integrous Big Hearts, Big Ideas Virtual Investor Conference
February 09, 2024
Via
ACCESSWIRE
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology
April 15, 2024
Via
Press Release Distribution Service
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology
April 15, 2024
New York, April 15, 2024 - (Plato Data) -- Benzinga has published a new article on Autonomix Medical Inc. (NASDAQ: AMIX), featuring the company's groundbreaking approach to peripheral nervous system...
Via
TheNewswire.com